Clinical trials conducted for testing efficacy of new drugs are set to become transparent with the launch of a national registry for recording such an exercise.
The Clinical Trials Registry - India (CTRI), the first such initiative in Asia, was launched at the Indian Council of Medical Research (ICMR) here on Friday.
Any researcher who plans to conduct drug trials on humans is expected to declare the details of the exercise in the Registry, that is jointly funded by the Department of Science and Technology, WHO and ICMR.
Such prospective registration of clinical trials in humans before enrolling the first participant, and making sufficient information of ongoing research available to all those involved in healthcare decision making is now a national and international priority.
"With the launch of this registry, India will be among the few select countries like Australia, UK and the US that are making researchers accountable through public disclosure," N K Ganguly, ICMR Director-General said…. "The CTRI will ensure that a complete view of ongoing research is available at the click of a mouse," Ganguly said….
Only trials properly registered will be considered for publication in international research journals.
Posted by
Peter Suber at 7/24/2007 04:45:00 PM.
The open access movement:
Putting peer-reviewed scientific and scholarly literature
on the internet. Making it available free of charge and
free of most copyright and licensing restrictions.
Removing the barriers to serious research.
I recommend the OA tracking project (OATP) as the best way to stay on top of new OA developments. You can read the OATP feed on a blog-like web page or subscribe to it by RSS, email, or Twitter. You can also help build the feed by tagging new developments you encounter.
